Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$6.74 USD
-0.23 (-3.30%)
Updated May 3, 2024 04:00 PM ET
After-Market: $6.71 -0.03 (-0.45%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Income Statements
Fiscal Year end for Aurora Cannabis Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | NA | 175 | 191 | 208 |
Cost Of Goods | NA | NA | 158 | 208 | 233 |
Gross Profit | NA | NA | 17 | -17 | -25 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 0 | 200 | 204 | 341 |
Income After Depreciation & Amortization | 0 | 0 | -183 | -221 | -366 |
Non-Operating Income | NA | NA | -1,119 | -274 | -2,099 |
Interest Expense | NA | NA | 57 | 52 | 58 |
Pretax Income | NA | NA | -1,359 | -546 | -2,523 |
Income Taxes | NA | NA | -2 | -5 | -62 |
Minority Interest | NA | NA | 0 | 0 | 0 |
Investment Gains/Losses | NA | NA | 0 | 0 | 0 |
Other Income/Charges | NA | NA | 0 | 0 | 0 |
Income From Cont. Operations | NA | NA | -1,357 | -541 | -2,461 |
Extras & Discontinued Operations | NA | NA | 0 | -1 | -7 |
Net Income (GAAP) | NA | NA | -1,357 | -543 | -2,468 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 0 | -109 | -144 | -280 |
Depreciation & Amortization (Cash Flow) | NA | NA | 74 | 77 | 86 |
Income After Depreciation & Amortization | 0 | 0 | -183 | -221 | -366 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | NA | 21.49 | 16.91 | 9.68 |
Diluted EPS Before Non-Recurring Items | NA | -4.50 | -18.10 | -18.50 | -28.60 |
Diluted Net EPS (GAAP) | NA | -24.90 | -63.15 | -32.10 | -255.10 |
Fiscal Year end for Aurora Cannabis Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 47.31 | 47.27 | 55.87 | 47.35 |
Cost Of Goods | NA | 32.77 | 21.59 | 37.25 | NA |
Gross Profit | NA | 14.54 | 25.67 | 18.62 | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 32.08 | 33.91 | 30.61 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -17.54 | -8.24 | -11.99 | 0.00 |
Non-Operating Income | NA | 0.87 | 11.67 | -0.49 | NA |
Interest Expense | NA | 1.89 | 3.15 | 3.97 | NA |
Pretax Income | NA | -18.57 | 0.29 | -16.44 | NA |
Income Taxes | NA | -0.05 | 0.10 | 0.07 | NA |
Minority Interest | NA | -1.03 | -1.20 | -5.62 | NA |
Investment Gains/Losses | NA | 0.00 | 0.00 | NA | NA |
Other Income/Charges | NA | 0.00 | 0.00 | NA | NA |
Income From Cont. Operations | NA | -18.52 | 0.19 | -16.52 | -60.65 |
Extras & Discontinued Operations | NA | -0.25 | -1.78 | -4.56 | 0.00 |
Net Income (GAAP) | NA | -17.74 | -0.39 | -15.45 | -60.65 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 47.42 | 38.40 | 35.36 | 32.27 |
Diluted EPS Before Non-Recurring Items | NA | -0.20 | -0.50 | -0.40 | -1.50 |
Diluted Net EPS (GAAP) | NA | -0.37 | -0.10 | -0.45 | -1.80 |